Home NDC 71288-818-81 YUSIMRY
Product NDC 71288-818
Requested package NDC 71288-818-81
11-digit product format 712880818
Labeler code 71288
Product ID 71288-818_b027a90d-7a56-4c43-b86f-088d7e335f7e
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name adalimumab-aqvh
Dosage form INJECTION, SOLUTION
Route SUBCUTANEOUS
Labeler Meitheal Pharmaceuticals Inc.
Application BLA761216
Marketing category BLA
Marketing start 2026-09-25
Substance ADALIMUMAB
Active strength 80 mg/.8mL
Pharmacologic classes Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join YUSIMRY ADALIMUMAB-AQVH Coherus BioSciences Inc cd0e7af2-7704-49ce-bde9-f645294b6788 2025-05-16 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA761216
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761216 Yusimry adalimumab-aqvh 351(k) Interchangeable Rx 2026-09-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 71288-818-81 71288081881 2 SYRINGE, GLASS in 1 CARTON (71288-818-81) / .8 mL in 1 SYRINGE, GLASS 2026-09-25 No No Historical